|
NFKBIZ expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.737460E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.497700E-02 |
| Normal-vs-Stage2 |
7.302200E-02 |
| Normal-vs-Stage3 |
4.180800E-03 |
| Normal-vs-Stage4 |
1.020150E-03 |
| Stage1-vs-Stage2 |
7.975000E-01 |
| Stage1-vs-Stage3 |
1.818390E-01 |
| Stage1-vs-Stage4 |
3.107700E-02 |
| Stage2-vs-Stage3 |
4.730400E-01 |
| Stage2-vs-Stage4 |
1.008220E-01 |
| Stage3-vs-Stage4 |
2.770600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.016600E-03 |
| Normal-vs-AfricanAmerican |
4.744200E-02 |
| Normal-vs-Asian |
5.752100E-02 |
| Caucasian-vs-AfricanAmerican |
3.141200E-01 |
| Caucasian-vs-Asian |
9.600000E-02 |
| AfricanAmerican-vs-Asian |
9.372100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.513900E-02 |
| Normal-vs-Female |
1.844780E-04 |
| Male-vs-Female |
2.359600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.576100E-02 |
| Normal-vs-Age(41-60Yrs) |
3.380900E-03 |
| Normal-vs-Age(61-80Yrs) |
1.542410E-02 |
| Normal-vs-Age(81-100Yrs) |
1.149170E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.738800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.949010E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.888200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.737400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.652000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.407600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.848600E-01 |
| Normal-vs-Grade 2 |
4.956200E-02 |
| Normal-vs-Grade 3 |
7.396500E-03 |
| Normal-vs-Grade 4 |
3.036200E-04 |
| Grade 1-vs-Grade 2 |
8.135000E-01 |
| Grade 1-vs-Grade 3 |
5.853200E-01 |
| Grade 1-vs-Grade 4 |
4.318100E-02 |
| Grade 2-vs-Grade 3 |
4.665000E-01 |
| Grade 2-vs-Grade 4 |
8.223500E-03 |
| Grade 3-vs-Grade 4 |
2.041500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.831600E-01 |
| Normal-vs-ccB subtype |
4.04160000000431E-05 |
| ccA subtype-vs-ccB subtype |
1.48079999995332E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.238800E-03 |
| Normal-vs-N1 |
7.028200E-02 |
| N0-vs-N1 |
2.400200E-01 |
|
|
